Virat Kohli steers India past Australia and into Champions Trophy final
Football Daily | Will the Gunners sink or swim as they return to the Round of Arsenal?
Newcastle chief says club ‘would be crazy’ to consider selling Alexander Isak
Emma Raducanu’s stalking incident gives results a different complexion
Club Brugge v Aston Villa: Champions League last 16, first leg – live
Pembrolizumab is used to treat triple-negative form of disease but researchers say it could be used more widely
Thousands more women with breast cancer could benefit from a blockbuster immunotherapy drug than previously thought, research suggests.
Pembrolizumab, sold under the brand name Keytruda, targets and blocks a specific protein on the surface of certain immune cells that then seek out and destroy the cancerous cells.
More Stories
Microsoft unveils chip it says could bring quantum computing within years
Virologist Wendy Barclay: ‘Wild avian viruses are mixing up their genetics all the time. It’s like viral sex on steroids’
Why Elon Musk is targeting a free tax-filing software